Sambai, Betsy C.
Kingston, Hanley
Monroe-Wise, Aliza
Mbogo, Loice
Juma, Emily
Ludwig-Barron, Natasha
Guthrie, Brandon L.
Bukusi, David
Chohan, Bhavna H.
Scott, John
Bosire, Rose
Dunbar, Matthew
Macharia, Paul
Masyuko, Sarah
Sinkele, William
Herbeck, Joshua T.
Farquhar, Carey
Funding for this research was provided by:
U.S. Department of Health and Human Services (T32GM81062)
Fogarty International Center (D43TW009580)
NIH diversity supplement through the National Institute of Drug Abuse (R01DA043409-S1)
U.S. National Institutes of Health (R01DA043409)
Article History
Received: 3 September 2021
Accepted: 5 January 2022
First Online: 21 January 2022
Declarations
:
: This study was carried out in accordance with the Declaration of Helsinki and following ethical guidelines of The University of Washington and Kenyatta National Hospital. Ethical approval was provided by the Institutional Review Board at the University of Washington (STUDY00001536) and the Ethical Review Committee at Kenyatta National Hospital/University of Nairobi (P265/05/2017). All the participants in this study gave informed consent to participate and have their data published.Consent for publicationNot applicable.
: Not applicable.
: JS has received advisory fees from Gilead Sciences. All other authors state that they have no competing interests.